Longevity Health Holdings, Inc.
XAGE- Exchange
- OTC
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- SEC CIK
- 0001842939
No open-market purchases or sales by Longevity Health Holdings, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $4.84K in total; no superinvestor holds it.
Other share classesXAGEW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Longevity Health Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Longevity Health Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ajjarapu J. Ram | Chief Executive Officer | 689,656Indirect | Apr 8, 2026 | 1 |
| Upton Richard A | Director | 15,000 | Nov 8, 2024 | 0 |
| Shukla Rajiv | Chairman and CEO | 4,249,908Indirect | Nov 8, 2024 | 0 |
| Gregory Kathryn | Director | 22,500Indirect | Nov 8, 2024 | 0 |
| Sturgeon Patrick A | Director | 18,051Indirect | Nov 8, 2024 | 0 |
| Spenlehauer Gilles | Director | 7,598Indirect | Nov 8, 2024 | 0 |
| Frisch Scott M. | Director | 7,598Indirect | Nov 8, 2024 | 0 |
| Cassaday Bryan J. | Chief Financial Officer | 4,250 | Nov 8, 2024 | 0 |
| Bracken-Ferguson Kendra | Chief Executive Officer | – | Nov 8, 2024 | 0 |
| Anderson David W | Director | 8,128Indirect | Aug 30, 2024 | 0 |
| Hubbell Randolph W | President and CEO | 2,750 | Aug 30, 2023 | 0 |
| Newlin William R | Director | – | Jul 18, 2023 | 0 |
| Bariahtaris Steven | Director | – | Jul 18, 2023 | 0 |
| AHAC Sponsor III LLC | 10% Owner | 4,249,908 | Jul 18, 2023 | 0 |
| Garza Jaime | Director | – | Jul 18, 2023 | 0 |
| Vargo Janet | VP Clinical Services | 27,030 | Jul 18, 2023 | 0 |
| Godward Donna | Chief Quality Officer | 37,296 | Jul 18, 2023 | 0 |
| Hart James C | Chief Medical Officer | 37,307 | Jul 18, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 (view filing) | Sep 6 | 4 days | Spenlehauer GillesDirector | PPurchase | +1.01K | $0.51 | +$514.59 | +15.3%7.60K after | Duplicate filing |
| Sep 10, 2024 (view filing)4:30 PM ET | Sep 10 | Same day | Cassaday Bryan J.Chief Financial Officer | PPurchase | +475 | $0.46 | +$218.5 | +12.6%4.25K after | |
| Sep 16, 2024 (view filing)4:30 PM ET | Sep 13 | 3 days | Upton Richard ADirector | PPurchase | +5.00K | $0.4672 | +$2.34K | +50.0%15.0K after | |
| Apr 8, 2026 (view filing)5:47 PM ET | Mar 16 | 23 daysLate | Ajjarapu J. RamChief Executive Officer | PPurchase | +689.7K | $0.29 | +$200.0K | New position689.7K after |